Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Pharmacokinetics and tolerability of oseltamivir combined with probenecid
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacokinetics and tolerability of oseltamivir combined with probenecid'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tolerability
100%
Pharmacokinetics
100%
Oseltamivir
100%
Probenecid
100%
Confidence Interval
50%
Mean Concentration
50%
Oseltamivir Carboxylate
25%
Between-group
12%
Steady State
12%
Oral Clearance
12%
Healthy Volunteers
12%
Virus Infection
12%
Noncompartmental
12%
Ratio of Means
12%
Geometric Mean
12%
Dosing Strategy
12%
Pharmacokinetic Analysis
12%
Arithmetic Mean
12%
Safety Data
12%
Thrombocytopenia
12%
Pharmacokinetic Data
12%
Twice a Day
12%
Influenza Virus
12%
Influenza B Virus
12%
Neuraminidase Inhibitors
12%
Criterion Boundaries
12%
Bioequivalence
12%
Alternative Dosing
12%
Influenza Neuraminidase
12%
Influenza Pandemic
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Probenecid
100%
Oseltamivir
100%
Pharmacokinetics
100%
4 Acetamido 5 Amino 3 (1 Ethylpropoxy) 1 Cyclohexene 1 Carboxylic Acid
25%
Normal Human
12%
Virus Infection
12%
Thrombocytopenia
12%
Influenza B Virus
12%
Bioequivalence
12%
Influenzavirus A
12%
Sialidase
12%
Virus Sialidase
12%
Pandemic Influenza
12%
Influenza Virus
12%